“…Firstly, a higher drug concentration can create a higher supersaturation that favors to form a faster nucleation rate, resulting in small particle size (Chen et al, 2004;Matteucci et al, 2006); secondly, as the concentration was gradually increased to 35 mg/mL, the increased viscosity of drug solution hindered the diffusion between solution and antisolvent, thereby promoting aggregation of particles (Kakran et al, 2010;Zhang et al, 2006); finally, the much higher drug concentration, 35 mg/mL, also brought about a large number of nuclei in the interface of antisolvent and solvent. So the diffusion from solvent to antisolvent was decreased and subsequent agglomeration occurred (Kakran et al, 2010;Matteucci et al, 2006). As a result, 30 mg/mL was chosen to be one of the optimum conditions for preparation of m-EA.…”